Literature DB >> 33675089

Whole family-based Helicobacter pylori eradication is a superior strategy to single-infected patient treatment approach: A systematic review and meta-analysis.

Jun-Bo Zhao1, Lin Yuan1, Xue-Chun Yu1, Qiao-Qiao Shao1, Jing Ma1, Miao Yu1, Yue Wu1, Ya-Bin Qi1, Ruo-Bing Hu1, Pei-Ru Wei1, Bai-Ling Jia1, Lian-Zhong Zhang2, Yan-Rui Zhang1, Song-Ze Ding1.   

Abstract

BACKGROUND: Two critical concerns during Helicobacter pylori (H. pylori) eradication are the successful eradication and recurrence. It is debatable whether whole family-based H. pylori treatment regimen might have any advantage over single-infected patient treatment approach in increasing eradication rate and reducing recurrence rate. We conduct systematic review and meta-analysis to compare the efficacy of these two treatment regimens in order to provide clinical practice a better option for H. pylori eradication.
METHODS: Randomized controlled trials evaluating H. pylori eradication and recurrence in whole family-based treatment group (WFTG) versus single-infected patient treatment group (SPTG) were collected from published literature up to July 2020 from common databases. Pooled results were analyzed using either fixed-effect or random-effect model. Results were expressed as the odds ratio (OR) and 95% confidence interval (CI).
RESULTS: A total of 1751 relevant articles were identified, and 12 studies were eligible for analysis. Among them: (a) Eight articles including 1198 patients were selected to analyze H. pylori eradication rate, pooled result showed that eradication rate of WFTG was higher than that of SPTG (OR=2.93; 95% CI 1.68-5.13). Stratified analysis showed that H. pylori eradication rate in WFTG were higher over SPTG in children subgroup, but had no difference in spouse subgroup. (b) Six studies including 881 patients were analyzed for recurrence rate between the two groups, pooled analysis showed that the overall recurrence rate of WFTG was lower than that of SPTG (OR=0.3; 95% CI 0.19-0.48). Stratified analysis showed that the recurrence rate in WFTG was lower over SPTG at 6, 12, 18, and more than 24 months post-treatment subgroups.
CONCLUSION: Whole family-based H. pylori treatment can partially increase eradication rate and reduce recurrence rate over single-infected patient treatment approach, the results provide clinical practice a novel notion for H. pylori eradication and infection prevention.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Hzzm321990. zzm321990pylorizzm321990; eradication rate; family co-treatment; meta-analysis; recurrence rate

Year:  2021        PMID: 33675089     DOI: 10.1111/hel.12793

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  3 in total

Review 1.  Treatment of Pediatric Helicobacter pylori Infection.

Authors:  Hung-Hsiang Lai; Ming-Wei Lai
Journal:  Antibiotics (Basel)       Date:  2022-06-01

2.  Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition).

Authors:  Song-Ze Ding; Yi-Qi Du; Hong Lu; Wei-Hong Wang; Hong Cheng; Shi-Yao Chen; Min-Hu Chen; Wei-Chang Chen; Ye Chen; Jing-Yuan Fang; Heng-Jun Gao; Ming-Zhou Guo; Ying Han; Xiao-Hua Hou; Fu-Lian Hu; Bo Jiang; Hai-Xing Jiang; Chun-Hui Lan; Jing-Nan Li; Yan Li; Yan-Qing Li; Jie Liu; You-Ming Li; Bin Lyu; You-Yong Lu; Ying-Lei Miao; Yong-Zhan Nie; Jia-Ming Qian; Jian-Qiu Sheng; Cheng-Wei Tang; Fen Wang; Hua-Hong Wang; Jiang-Bin Wang; Jing-Tong Wang; Jun-Ping Wang; Xue-Hong Wang; Kai-Chun Wu; Xing-Zhou Xia; Wei-Fen Xie; Yong Xie; Jian-Ming Xu; Chang-Qing Yang; Gui-Bin Yang; Yuan Yuan; Zhi-Rong Zeng; Bing-Yong Zhang; Gui-Ying Zhang; Guo-Xin Zhang; Jian-Zhong Zhang; Zhen-Yu Zhang; Peng-Yuan Zheng; Yin Zhu; Xiu-Li Zuo; Li-Ya Zhou; Nong-Hua Lyu; Yun-Sheng Yang; Zhao-Shen Li
Journal:  Gut       Date:  2021-11-26       Impact factor: 23.059

3.  Family-based Helicobacter pylori infection status and transmission pattern in central China, and its clinical implications for related disease prevention.

Authors:  Xue-Chun Yu; Qiao-Qiao Shao; Jing Ma; Miao Yu; Chen Zhang; Lei Lei; Yang Zhou; Wen-Chao Chen; Wei Zhang; Xin-Hui Fang; Yuan-Zeng Zhu; Gang Wu; Xue-Mei Wang; Shuang-Yin Han; Pei-Chun Sun; Song-Ze Ding
Journal:  World J Gastroenterol       Date:  2022-07-28       Impact factor: 5.374

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.